BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21764458)

  • 1. Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
    Shalchi Z; Gurbaxani A; Baker M; Nash J
    Ophthalmology; 2011 Nov; 118(11):2161-5. PubMed ID: 21764458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G; Alfonso EC; Miller D
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial keratitis in Waikato, New Zealand.
    Pandita A; Murphy C
    Clin Exp Ophthalmol; 2011 Jul; 39(5):393-7. PubMed ID: 21176039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
    Goldstein MH; Kowalski RP; Gordon YJ
    Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
    Orlans HO; Hornby SJ; Bowler IC
    Eye (Lond); 2011 Apr; 25(4):489-93. PubMed ID: 21252952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial keratitis in Christchurch, New Zealand, 1997-2001.
    Hall RC; McKellar MJ
    Clin Exp Ophthalmol; 2004 Oct; 32(5):478-81. PubMed ID: 15498058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014.
    Al-Dhaheri HS; Al-Tamimi MD; Khandekar RB; Khan M; Stone DU
    Cornea; 2016 Jun; 35(6):789-94. PubMed ID: 27078003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia.
    Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL
    Clin Exp Ophthalmol; 2020 Mar; 48(2):183-191. PubMed ID: 31671232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.
    Tan SZ; Walkden A; Au L; Fullwood C; Hamilton A; Qamruddin A; Armstrong M; Brahma AK; Carley F
    Eye (Lond); 2017 Aug; 31(8):1229-1236. PubMed ID: 28452995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and causative organisms in microbial keratitis.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
    Wilhelmus KR; Abshire RL; Schlech BA
    Arch Ophthalmol; 2003 Sep; 121(9):1229-33. PubMed ID: 12963604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth.
    Tavassoli S; Nayar G; Darcy K; Grzeda M; Luck J; Williams OM; Tole D
    Eye (Lond); 2019 Oct; 33(10):1619-1625. PubMed ID: 31073162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.
    Kunimoto DY; Sharma S; Garg P; Rao GN
    Ophthalmology; 1999 Jan; 106(1):80-5. PubMed ID: 9917785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Queensland Microbial Keratitis Database: 2005-2015.
    Green M; Carnt N; Apel A; Stapleton F
    Br J Ophthalmol; 2019 Oct; 103(10):1481-1486. PubMed ID: 30612096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
    Sand D; She R; Shulman IA; Chen DS; Schur M; Hsu HY
    Ophthalmology; 2015 May; 122(5):918-24. PubMed ID: 25600200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.
    Ly CN; Pham JN; Badenoch PR; Bell SM; Hawkins G; Rafferty DL; McClellan KA
    Clin Exp Ophthalmol; 2006; 34(1):44-50. PubMed ID: 16451258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
    Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pattern and antibiotic sensitivity of bacterial corneal ulcers in Kano, Northern Nigeria.
    Abubakar UM; Lawan A; Muhammad I
    Ann Afr Med; 2018; 17(3):151-155. PubMed ID: 30185685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.